Express News | Pharmather Holdings Ltd - Generic Drug User Fee Amendments of 2022 Goal Date of October 29, 2024

ReutersMay 10 08:00 ET

Express News | Pharmather Holdings Ltd - Receipt of Amendment Acknowledgment Letter for Its Priority Original Abbreviated New Drug Application for Ketamine

ReutersMay 10 07:59 ET

Express News | Pharmather Holdings Ltd - Receipt of a Complete Response Letter ("Crl") for Its Priority Original Abbreviated New Drug Application for Ketamine

Moomoo 24/7Apr 18 16:00 ET

Express News | Pharmather Holdings Ltd: Has Completed Necessary Tests and Responses to Address Fda's Comments

Moomoo 24/7Apr 18 16:00 ET

PharmaTher Updated on Its Priority Original Abbreviated New Drug Application for Ketamine

PharmaTher Holdings Ltd. (PHRM.CN), a specialty pharmaceutical company, on Tuesday provided an update on its Priority Original Abbreviated New Drug Application (ANDA) for Ketamine that was accepted by

MT NewswiresApr 16 08:39 ET

PharmaTher Provides Update on Its Priority Original Abbreviated New Drug Application For Ketamine

PharmaTher Holdings Ltd. (PHRM.CSE), a commercial-focused specialty pharmaceutical company, on Monday provided an update on its Priority Original Abbreviated New Drug Application (ANDA) for Ketamine t

MT NewswiresFeb 12 08:43 ET